Trial Profile
Phase I Study of M2ES Combined Gemcitabine in Patients With Advanced Pancreatic Cancer.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Endostatin (Primary) ; Gemcitabine
- Indications Pancreatic cancer
- Focus Adverse reactions
- 18 Oct 2010 New trial record